MARAPHARM VENTURES COM NPV (OTCMKTS:MRPHF) Steadily Moving Forward

Growth in the cannabis industry has prompted companies to expand in preparation for the growth in demand for cannabis. Canadian cannabis companies are rushing to gain an advantage in light of the upcoming implementation of legislation that legalizes cannabis for recreational use. MARAPHARM VENTURES COM NPV (OTCMKTS:MRPHF) has recently taken significant steps to expand its production capacity.First, some background on the company. Marapharm Ventures Inc. is a publicly traded company, primarily investing in the medical and recreational cannabis space, with operations based in British Columbia, Canada. Through its wholly owned operating subsidiary Marapharm Inc., the Company has applied to Health Canada to become a licensed producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company’s growth strategy will be to build facilities or acquire licenses in the United States, determined by identifying opportunities in the market. The company has currently focused its attention on opportunities in Nevada, Washington and California. Land has been purchased and construction has begun in the Apex Business Park in the City of North Las Vegas, Nevada. The company’s intention is to build cultivation and processing facilities in this location.On May 25, 2017, Marapharm announced that it has completed an important step in the licensing process. All necessary Nevada State taxes and fees have been paid, and two cultivation licenses and one production license have been approved and issued for medical marijuana. This step now qualifies the Company to apply for a license to grow and sell recreational marijuana. The application has been submitted along with the applicable State taxes and fees. Once the licensing process, and construction of the facility are both completed, Marapharm can begin growing and cultivating marijuana for both medical and recreational sale. Accordingly, the completion of the licensing process coincides well with the first anticipated sales of recreation marijuana in Nevada, which are expected to take place in July of this year.Marapharm announced on April 17, 2017 that it purchased, without contingencies, 1.22 acres of property located in Desert Hot Springs, CA, zoned industrial and approved for cultivation and processing of cannabis. Soon thereafter on May 2, 2017, the Company announces that it entered into an agreement to purchase an additional 7.02 acres also located in Desert Hot Springs, CA.In the State of Washington, Marapharm received approval on March 9, 2017 from the State LCB (Liquor Control Board) for the plans submitted for the construction and renovation of one of the 30,000 square foot buildings located on the recently purchased 13.6 acres of industrial highway frontage property located a few minutes south of the Canadian border. Marapharm’s ultimate objective for the site is to create a cannabis campus.

MRPHF stock has been on a downward trend since mid-November of 2016 when it made its all-time high of $1.87 on November 16, 2016 after a run-up that started in July of 2016. At present, the stock is trading at $.8188, right around the 50% retracement area. Volume remains strong. According to the financials, the company is pre-revenue, but the balance sheet indicates a decent cash position necessary to maintain its operations.In a recent press release dated June 1, 2017, Marapharm Ventures Inc announced an upcoming corporate transaction to sell Marapharm’s Health Canada ACMPR (Access to Cannabis for Medical Purposes Regulations) license application, and all associated property, plans, and intellectual property to Standard Graphite Corporation (TSXV:SGH), a public company on the TSX Venture Exchange (TSXV). The transaction would further bolster Marapharm’s balance sheet. The press release offered no further information on the details of the transaction with respects to how the Company’s operations would be affected. Current market capitalization stands at $73.94 million, on 79.74 million shares outstanding as of June 2, 2017.Marapharm Ventures Inc is executing its current plan on schedule, and has a coherent strategy for the future. Once marijuana growing and cultivating operations begin, revenues will begin to flow into the company, and growth will follow. This is defiantly one to keep a close eye on. We will be updating our subscribers as soon as we know more. For the latest updates on MRPHF, sign up below!Disclosure: We have no position in any of the securities mentioned and have not been compensated for this article.